1Chuang Y J, Kim JW. Novel Oncgene HCCR: its diagnostic and therapeutic implications for cancer. Histol Histopathol, 2005, 20(3) :999 - 1 003.
2Ko J, Lee YH, Hwang SY, et al. Identification and differential expression of novel human cervical cancer oneogene HCCR -2 in human cancers and its involvement in P53 stabili- zation, 2003, 22(30) :4 679 -4 689.
3Ko J, Shin SM, Oh YM, et al. Transgenie mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR- 2 transgenic mice. Oncogene, 2004,23 (10) :1 950 - 1 953.
4Cho GW, Shin SM, Kim HK,et al. The phosphatidylinositol 3 - kinase/Akt pathway regulates the HCCR - 1 oncogene expression. Gene ,2006,384 : 18 - 26.
5Shin SM, Chung YJ, Kim JW, et al. HCCR - 1 - Interacting Molecule" Deleted in Polyposis 1 "Plays a Tumor- Suppressor Role in Colon Carcinogenesis. Gastroenterology, 2006, 130:2 074 -2 086.
6Yoon SK, Lim NK, Ha SA, et al. The Human Cervical Cancer Oneogene Protein Is a Biomarker for Human Hepatoeellular Carcinorna. Cancer Res ,2004,64(15) :5 434-5 441.
7Ko J, Lee YH, Hwang SY, et al. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene, 200:3, 22:4679-4689.
8Ko J, Shin SM, Oh YM, et al. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice. Oncogene, 2004, 23:1950-1953.
9Satoh K, Kaneko K, Hirota M, et al. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer, 2001, 92 : 271-278.
10Hoffman WH, Biade S, Zilfou JT, et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem, 2002, 277 ::3247-3257.
